
News|Articles|December 1, 2008
December 2008 Oncology News International
Advertisement
Cover Story
Clara Bloomfield: Buck conventional wisdom always
New breast cancer program reduces time to treatment
ACS expert warns that global burden of cancer will skyrocket without prevention
DEPARTMENTS
Focus on Hematology
CyBorD combo supports stem cell collection in newly diagnosed multiple myeloma
Vantage Point: Rate of response to CyBorD is 'truly remarkable'
Focus on Lung Cancer
Final AVAiL results confirm longer PFS with bevacizumab
Focus on Colon Cancer
New presurgical strategies render colon mets resectable
Vantage Point: Converting unresectable to resectable: Data still limited
Focus on Breast Cancer
Brachytherapy improves treatment in augmented women
Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Zanidatamab-Based Regimens for First-Line HER2+ Gastric Cancers
2
FDA Grants Priority Review to Dostarlimab in dMMR/MSI-H Rectal Cancer
3
Lenvatinib Combo Holds Ground Against HER2 ADCs in Endometrial Cancer
4
FDA Grants Fast Track Designation to ERAS-0015 for Pancreatic Adenocarcinoma
5






























































